Ondine Biomedical Inc. (AIM:OBI)
London · Delayed Price · Currency is GBP · Price in GBX 15.30
+0.30 (2.00%)
May 26, 2026, 4:07 PM GMT
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 77.93 million as of May 26, 2026. Its market cap has increased by 99.80% in one year.
Market Cap
77.93M
Enterprise Value
75.25M
Revenue
1.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.30
Market Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 77.93M, a decrease of -30.95%. That is a compound annual growth rate of -7.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 77.93M | 100.49% |
| Dec 31, 2025 | 38.87M | 9.33% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
| Dec 6, 2021 | 112.86M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 228.31M |
| Bioventix | 87.52M |
| Faron Pharmaceuticals Oy | 82.80M |
| 4basebio | 75.07M |
| hVIVO | 55.65M |
| Hemogenyx Pharmaceuticals | 46.92M |
| Poolbeg Pharma | 35.54M |
| Sareum Holdings | 28.41M |